Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Stock Information | RedChip

Cyclerion Therapeutics Inc. (NASDAQ: CYCN) Listen to this Section


$3.11
+0.2150 ( +7.44% ) 2.4K

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Market Data


Open


$3.11

Previous close


$2.89

Volume


2.4K

Market cap


$6.31M

Day range


$2.80 - $2.89

52 week range


$1.75 - $5.25

Insider Ownership Transactions

Total Amount Purchased: -185,857.00 | $ -577,085.99

Date Type Amount Purchased Purchaser
2024-08-07 Sale -55849.00 Graul Regina Margaret
2024-01-26 Sale -50000.00 Graul Regina Margaret
2024-01-26 Sale -15000.00 Hecht Peter M
2023-12-04 Sale -20000.00 Hyman Steven
2023-12-04 Sale -20000.00 DESOUZA ERROL B
2023-12-04 Sale -20000.00 Hecht Peter M
2023-12-04 Sale -5000.00 MCGUIRE TERRANCE
2023-08-11 Sale -8.00 MCGUIRE TERRANCE

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
8-k 8K-related 15 Aug 07, 2024
8-k 8K-related 13 Jun 14, 2024
10-q Quarterly Reports 62 May 07, 2024
def Proxies and info statements 4 Apr 29, 2024
8-k 8K-related 13 Apr 18, 2024
3 Insider transactions 1 Mar 11, 2024
10-k Annual reports 96 Mar 05, 2024
4 Insider transactions 1 Jan 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.